Zurn Elkay (NYSE: ZWS) director granted 582 shares for fees in filing

Rhea-AI Filing Summary

Zurn Elkay Water Solutions director David C. Longren reported receiving 582 shares of common stock on January 15, 2026 as compensation. The shares were awarded at a price of $47.27 per share as payment of director fees in the form of restricted stock units. According to the disclosure, these units vested immediately but will not be paid out until six months after his service as a director ends. Following this award, Longren beneficially owned 94,710 shares of Zurn Elkay common stock in direct ownership.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Longren David C.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	582	$47.27	$28K

Holdings After Transaction: Common Stock — 94,710 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Longren David C.

(Last) (First) (Middle)

511 W. FRESHWATER WAY

(Street)

MILWAUKEE WI 53204

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Zurn Elkay Water Solutions Corp [ ZWS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		A(1)		582(1)	A	$47.27	94,710	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Payment of director fees in restricted stock units, which vested immediately, but is not paid out until six months after the Reporting Person's cessation of service as a director.

Remarks:

	/s/ Jeffrey J. LaValle under Power of Attorney for David C. Longren	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ZWS director David C. Longren report?

David C. Longren reported an acquisition of 582 shares of Zurn Elkay common stock on January 15, 2026 as shown in the Form 4.

At what price were the 582 Zurn Elkay (ZWS) shares recorded in the Form 4?

The 582 shares were reported at a price of $47.27 per share in the Form 4 filing.

How many ZWS shares does David C. Longren own after this transaction?

After the reported transaction, David C. Longren beneficially owned 94,710 shares of Zurn Elkay common stock in direct ownership.

What is the nature of the equity received by the ZWS director?

The filing states the transaction is a payment of director fees in restricted stock units, which vested immediately.

When will the restricted stock units reported by ZWS director be paid out?

The restricted stock units are not paid out until six months after David C. Longren’s cessation of service as a director.

Is the ZWS Form 4 transaction by David C. Longren direct or indirect ownership?

The Form 4 reports the ownership of the Zurn Elkay shares as Direct (D) for David C. Longren.